Skip to main content

Table 1 Correlation between the clinicopathological factors and expression of miR-205-5p and ANGPT2 in endometriosis

From: miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells

  miR-205-5p expression ANGPT2 expression
High Low P High Low P
Patients (n) 19 49   45 23  
Age (years) 31.26 ± 5.98 31.98 ± 6.36 0.67 32.18 ± 6.43 31.00 ± 5.85 0.464
Haemoglobin (g/L) 113.89 ± 15.08 114.80 ± 18.00 0.85 113.98 ± 18.07 115.65 ± 15.44 0.706
Endometrial phase (%)  
 Proliferative phase 78.95% 83.67%   82.22% 82.61%  
 Secretive phase 21.05% 16.33% 0.917 17.78% 17.39% 0.97
Dysmenorrhoea pain score (%)
 Less than 4 points 57.89% 30.61%   28.89% 56.52%  
 More than 4 points 42.11% 69.39% 0.038 71.11% 43.48% < 0.001
Chronic pelvic pain score (%)
 Less than 4 points 42.11% 36.69%   31.11% 47.83%  
 More than 4 points 57.89% 65.31% 0.57 68.89% 52.17% 0.18
 E2 (pmol/L) 369.58 ± 355.63 296.55 ± 301.26 0.245 276.76 ± 279.00 395.61 ± 373.30 0.054
 CA-125 (kU/L) 34.31 ± 21.27 109.55 ± 140.91 0.001 116.67 ± 144.86 33.47 ± 21.40 < 0.001
Endometriosis score (%)
 Less than 16 points 68.42% 38.78%   35.56% 69.57%  
 More than 16 points 31.58% 61.22% 0.028 64.44% 30.43% 0.008